MEI Pharma Inc  

(Public, NASDAQ:MEIP)   Watch this stock  
Find more results for MEIP
2.16
-0.02 (-0.92%)
Apr 24 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.06 - 2.22
52 week 1.69 - 8.55
Open 2.20
Vol / Avg. 734,917.00/3.10M
Mkt cap 71.91M
P/E     -
Div/yield     -
EPS -1.54
Shares 33.29M
Beta 1.90
Inst. own 80%
Apr 15, 2015
MEI Pharma Inc at Needham Healthcare Conference
Mar 4, 2015
MEI Pharma Inc at Cowen Health Care Conference
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -59.58% -62.88%
Return on average equity -66.15% -67.82%
Employees 19 -
CDP Score - -

Address

Suite 101, 11975 El Camino Real
SAN DIEGO, CA 92130
United States - Map
+1-858-7926300 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

MEI Pharma, Inc. is an oncology company. The Company is focused on the clinical development of therapies for cancer. The Company is focused on the development of lead drug candidate, Pracinostat, which is in three Phase II clinical trials. Pracinostat is an orally available histone deacetylase (HDAC) inhibitor that is being developed for advanced hematologic diseases such as myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). The Company�s clinical development pipeline includes isoflavone-based mitochondrial inhibitor drug candidate, ME-344.

Officers and directors

Daniel P. Gold Ph.D. President, Chief Executive Officer, Director
Age: 60
Bio & Compensation  - Reuters
Thomas M. Zech Chief Financial Officer, Secretary
Age: 63
Bio & Compensation  - Reuters
David M. Urso Senior Vice President, General Counsel
Age: 50
Bio & Compensation  - Reuters
Robert D. Mass M.D. Chief Medical Officer
Age: 60
Bio & Compensation  - Reuters
Christine Anna White M.D. Lead Independent Director
Age: 62
Bio & Compensation  - Reuters
Charles V. Baltic III Independent Director
Age: 53
Bio & Compensation  - Reuters
Leah Rush Cann Independent Director
Age: 54
Bio & Compensation  - Reuters
Kevan E. Clemens Ph.D. Independent Director
Age: 69
Bio & Compensation  - Reuters
Nicholas R. Glover Ph.D. Independent Director
Age: 45
Bio & Compensation  - Reuters